They also identified transcription factor 21 (TCF21) as a direct transcriptional regulator of ABCA10, providing valuable insights into the molecular mechanisms of ovarian cancer resistance to DDP and proposing potential avenues for therapeutic intervention [58]. This evidence concerns the gene ABCA10 and ovarian carcinoma.